Search research articles
Contact Us
Filters
Showing results (1-10 of 216) with videos related to
Page
of 22
Sort By:
Frontiers in Neurology
|
July 6, 2019
No Free Lunch With Herbal Preparations: Lessons From a Case of Parkinsonism and Depression Due to Herbal Medicine Containing Reserpine
Michel Rijntjes, Philipp T Meyer
Current Opinion in Neurology
|
June 21, 2014
Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis
Philipp T Meyer, Sabine Hellwig
Current Opinion in Neurology
|
July 1, 2014
Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases
Philipp T Meyer, Lars Frings, Sabine Hellwig
Current Opinion in Neurology
|
May 21, 2019
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis
Sabine Hellwig, Katharina Domschke, Philipp T Meyer
Clinical Nuclear Medicine
|
July 1, 2020
Lung Scintigraphy Imaging Features in a Young Patient With COVID-19
Christian Goetz, Thomas F Fassbender, Philipp T Meyer
Journal of Neurology
|
August 1, 2013
Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types
Annette Baumgartner, Sebastian Rauer, Irina Mader, et al.
Journal of Alzheimer'S Disease : JAD
|
November 20, 2020
Intrinsic Alertness Is Impaired in Patients with Nigrostriatal Degeneration: A Prospective Study with Reference to [123I]FP-CIT SPECT and [18F]FDG PET
Lars Frings, Bernhard Heimbach, Philipp T Meyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 16, 2017
<sup>18</sup>F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Philipp T Meyer, Lars Frings, Gerta Rücker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2020
Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Ganna Blazhenets, Lars Frings, Arnd Sörensen, et al.
Nuklearmedizin. Nuclear Medicine
|
November 15, 2019
Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy
Kerstin Michalski, Michael Mix, Philipp T Meyer, et al.
Page
of 22
Search research articles
Search
Showing results (1-10 of 216) with videos related to
Sort By:
Page
of 22
Frontiers in Neurology
|
July 6, 2019
No Free Lunch With Herbal Preparations: Lessons From a Case of Parkinsonism and Depression Due to Herbal Medicine Containing Reserpine
Michel Rijntjes, Philipp T Meyer
Current Opinion in Neurology
|
June 21, 2014
Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis
Philipp T Meyer, Sabine Hellwig
Current Opinion in Neurology
|
July 1, 2014
Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases
Philipp T Meyer, Lars Frings, Sabine Hellwig
Current Opinion in Neurology
|
May 21, 2019
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis
Sabine Hellwig, Katharina Domschke, Philipp T Meyer
Clinical Nuclear Medicine
|
July 1, 2020
Lung Scintigraphy Imaging Features in a Young Patient With COVID-19
Christian Goetz, Thomas F Fassbender, Philipp T Meyer
Journal of Neurology
|
August 1, 2013
Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types
Annette Baumgartner, Sebastian Rauer, Irina Mader, et al.
Journal of Alzheimer'S Disease : JAD
|
November 20, 2020
Intrinsic Alertness Is Impaired in Patients with Nigrostriatal Degeneration: A Prospective Study with Reference to [123I]FP-CIT SPECT and [18F]FDG PET
Lars Frings, Bernhard Heimbach, Philipp T Meyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 16, 2017
<sup>18</sup>F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Philipp T Meyer, Lars Frings, Gerta Rücker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2020
Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Ganna Blazhenets, Lars Frings, Arnd Sörensen, et al.
Nuklearmedizin. Nuclear Medicine
|
November 15, 2019
Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy
Kerstin Michalski, Michael Mix, Philipp T Meyer, et al.
Page
of 22